Home / Stockholms Medicinska Biobank / Covid-related tromboembolism; the impact of heriditary and aquired risk factors and biomarkers for disease and outcome
Collection
Covid-related tromboembolism; the impact of heriditary and aquired risk factors and biomarkers for disease and outcome
Description: Plasma, Serum and Whole blood at specific time points during one year after covid-19 related thromboembolism.
Acronym:
coVTE
Biobank:
Stockholms Medicinska Biobank
Local collection ID (within the biobank):
Bbk 2448
General information
Collection size:
100 - 1000
(as of 2021-01-17)
Type:
Disease specific
Hospital
Sample
Data:
Biological samples
Medical records
Start date of sampling:
2020-07-01
End date of sampling:
2024-12-01
Collection preserved at least until:
2026-01-01
Ethical approval number:
2020-03310
Donor information
Diagnoses:
Laboratory-confirmed COVID-19 diagnosis; U07.1
Number of donors:
100 - 1000
Inclusion criteria: Patients (18–69 yrs) referred to the Coagulation Unit, Karolinska University Hospital Solna or Huddinge for follow up after covid-19 related thromboembolism.
Exclusion criteria: Patients with main follow up after thrombosis at other unit due to: 1. other major disease (incl. cancer, reumatic disease, kidney disease etc.); 2. pregnancy. Patients with difficulty to understand study information.
Sample information
Materials:
Collection contact information
Collection head: Maria Magnusson
Contact person: Maria
Magnusson
maria.s.magnusson@regionstockholm.se
Biobank contact information
Stockholms Medicinska Biobank
Registration number at IVO: 914
biobankstockholm@regionstockholm.se